Published in J Clin Pathol on January 01, 1994
Local macrophage proliferation in multinucleated giant cell and granuloma formation in experimental Goodpasture's syndrome. Am J Pathol (1995) 0.87
Biological factors, tumor growth kinetics, and survival after metastasectomy for pulmonary melanoma. Ann Surg Oncol (2009) 0.84
Proliferative activity is a significant prognostic factor in male breast carcinoma. Am J Pathol (1994) 0.81
Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas. Br J Cancer (1996) 0.81
Prognostic value of MIB-1 index and DNA ploidy in resectable ampulla of Vater carcinoma. Ann Surg (1999) 0.77
Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem (1981) 38.93
Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer (1983) 11.19
Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol (1990) 5.90
Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. Proc Natl Acad Sci U S A (1985) 3.62
Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol (1989) 3.43
Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J Cell Sci (1990) 3.35
Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Hematol Oncol (1985) 2.35
The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis. Histopathology (1991) 2.32
The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology. Am J Surg Pathol (1986) 2.07
The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma. J Pathol (1988) 2.05
Ploidy, proliferative activity and prognosis. DNA flow cytometry of solid tumors. Cancer (1990) 2.00
Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67. J Clin Pathol (1986) 1.97
Cyclin: a nuclear protein whose level correlates directly with the proliferative state of normal as well as transformed cells. Leuk Res (1984) 1.79
Limits of detection of nuclear DNA abnormalities by flow cytometric DNA analysis. Results obtained by a set of methods for sample-storage, staining and internal standardization. Cytometry (1983) 1.56
Correlation between DNA flow cytometric and nucleolar organizer region data in non-Hodgkin's lymphomas. J Pathol (1988) 1.49
Flow cytometry in the diagnosis and classification of malignant lymphoma and leukemia. Cancer (1982) 1.46
Ki-67 derived proliferative activity in colorectal adenocarcinoma with prognostic correlations. J Pathol (1988) 1.36
Percentage of cells in the S phase of the cell cycle in human lymphoma determined by flow cytometry. Cytometry (1980) 1.33
Flow analysis of DNA content and cell size in non-Hodgkin's lymphoma. Cancer Res (1980) 1.32
A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours. J Pathol (1992) 1.17
Haemangiopericytomas: the prognostic value of immunohistochemical staining with a monoclonal antibody to proliferating cell nuclear antigen (PCNA). Histopathology (1991) 1.17
Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry. Am J Pathol (1990) 1.14
Proliferating cell nuclear antigen expression in central nervous system neoplasms. Virchows Arch A Pathol Anat Histopathol (1991) 1.13
Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlations. Am J Surg Pathol (1990) 1.10
A comparison of three methods for the determination of the growth fraction in non-Hodgkin's lymphoma. Br J Cancer (1987) 1.10
Growth fractions in human prostatic carcinoma determined by Ki-67 immunostaining. J Pathol (1988) 1.02
DNA content and kinetic characteristics of non-Hodgkin's lymphoma: determined by flow cytometry and autoradiography. Cytometry (1981) 0.99
Proliferation markers Ki-67 and p105 in soft-tissue lesions. Correlation with DNA flow cytometric characteristics. Am J Pathol (1990) 0.99
Steroid receptors and Ki-67 reactivity in ovarian cancer and in normal ovary: correlation with DNA flow cytometry, biochemical receptor assay, and patient survival. J Pathol (1990) 0.99
The prognostic significance of proliferative activity in poor histology non-Hodgkin's lymphoma: a flow cytometry study using archival material. Eur J Cancer Clin Oncol (1987) 0.99
Proliferation indices in malignant lymphomas. Clin Exp Immunol (1989) 0.90
Cell cycling in bladder carcinoma determined by monoclonal antibody Ki67. Br J Urol (1990) 0.88
Immunohistological determination of proliferative activity in seminomas. J Clin Pathol (1988) 0.88
Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value. Br J Cancer (1992) 0.86
Argyrophilic nucleolar organizer region counts and proliferating cell nuclear antigen scores are two reliable indicators of survival in pharyngeal carcinoma. J Cancer Res Clin Oncol (1992) 0.81
Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 antigen in human malignant hematopoietic cells. Acta Oncol (1991) 0.81
Prognostic value of cell proliferation in breast cancer as determined by proliferating cell nuclear antigen (PCNA) immunostaining. Anticancer Res (1992) 0.81
Comparison of nuclear DNA content in primary and metastatic differentiated thyroid carcinoma. Am J Clin Pathol (1988) 0.79
Argyrophilic nucleolar organizer region counts and Ki-67 scores in human renal cell carcinoma. Pathol Res Pract (1991) 0.78
A simplified working formulation of non-Hodgkin's lymphomas based on quantifiable histologic criteria. Cancer (1989) 0.77
Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet (2000) 6.12
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia (2006) 5.64
International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia. Leukemia (2007) 2.96
Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas. Oncogene (2000) 2.27
Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia. Blood (2001) 1.79
Eosinophilic gastroenteritis with ascites: a case report and review of the literature. Dig Dis Sci (2003) 1.51
Clinical-pathological changes in differentiated thyroid cancer (DTC) over time (1997-2010): data from the University Hospital "Maggiore della Carità" in Novara. Endocrine (2012) 1.50
Apocrine carcinoma of the skin. A clinicopathologic, immunocytochemical, and ultrastructural study. Cancer (1993) 1.48
Prognostic relevance of tumour-cell growth fraction in malignant non-Hodgkin's lymphomas. Lancet (1987) 1.34
Distribution of interferon-gamma receptor in human tissues. Eur J Immunol (1992) 1.30
Thyroid incidentaloma identified by ¹⁸F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance. Clin Endocrinol (Oxf) (2011) 1.25
Expression of beta 1B integrin isoform in CHO cells results in a dominant negative effect on cell adhesion and motility. J Cell Biol (1994) 1.24
Prognostic relevance of cell proliferation in head and neck tumors. Ann Oncol (2004) 1.23
A flow cytometry assay simultaneously detects independent apoptotic parameters. Cytometry (2001) 1.22
Pathology of thymic epithelial tumors. Curr Top Pathol (1986) 1.19
Overweight as an adverse prognostic factor for non-Hodgkin's lymphoma patients receiving high-dose chemotherapy and autograft. Bone Marrow Transplant (2000) 1.19
Vascular endothelial growth factor-C stimulates the migration and proliferation of Kaposi's sarcoma cells. J Biol Chem (1999) 1.18
Clinical significance of neuroendocrine carcinoma of the breast. Ann Oncol (2001) 1.16
Thymomas. A review of 169 cases, with particular reference to results of surgical treatment. Cancer (1986) 1.11
Detection of immunoglobulin kappa light chain rearrangements by polymerase chain reaction. An improved method for detecting clonal B-cell lymphoproliferative disorders. Am J Pathol (1999) 1.10
IL-12 inhibition of endothelial cell functions and angiogenesis depends on lymphocyte-endothelial cell cross-talk. J Immunol (2001) 1.10
Carcinogenicity of dimethylnitrosamine in Swiss mice. Br J Cancer (1966) 1.09
Growth stimulation of colorectal carcinoma cells via the c-kit receptor is inhibited by TGF-beta 1. J Cell Physiol (1997) 1.08
Immunohistological evidences of cortical and medullary differentiation in thymoma. Virchows Arch A Pathol Anat Histopathol (1985) 1.07
Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomas. Clin Exp Immunol (2007) 1.05
CD38 molecule: structural and biochemical analysis on human T lymphocytes, thymocytes, and plasma cells. J Immunol (1990) 1.04
Epidemiology of pleural mesothelioma in North-western Italy (Piedmont). Br J Ind Med (1972) 1.03
Murine cytomegalovirus replication in salivary glands is controlled by both perforin and granzymes during acute infection. Eur J Immunol (2000) 1.01
Castleman's disease. Adv Clin Path (2000) 1.00
Prognostic relevance of AgNORs in tumor pathology. Micron (2000) 1.00
Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family. Int J Cancer (1999) 0.99
Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. Blood (2000) 0.99
Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy. Blood (1999) 0.99
Sonographic appearance of aggressive angiomyxoma of the bladder. J Clin Ultrasound (1999) 0.99
Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas. Eur Arch Otorhinolaryngol (1997) 0.97
Detection of vascular endothelial growth factor/ vascular permeability factor in periapical lesions. J Endod (2003) 0.96
Differential expression of transforming growth factors-beta1, -beta2 and -beta3 in human colon carcinoma. Eur J Cancer (2001) 0.96
Can Ki67 immunostaining predict response to radiotherapy in oral squamous cell carcinoma? J Clin Pathol (1994) 0.96
[Pediatric clinical experimentation with rifampicin. Therapeutic effect and tolerance]. Clin Pediatr (Bologna) (1969) 0.96
Immunohistochemical evidence of active thymocyte proliferation in thymoma. Its possible role in the pathogenesis of autoimmune diseases. Am J Pathol (1987) 0.95
Signet ring cell lymphoma in salivary gland. An immunohistochemical and ultrastructural study. Appl Pathol (1984) 0.95
Expansion and molecular evolution of the interferon-induced 2'-5' oligoadenylate synthetase gene family. Mol Biol Evol (2000) 0.94
First reported Nocardia otitidiscaviarum infection in an AIDS patient in Italy. Mycopathologia (1994) 0.94
BRAF gene is not mutated in plasma cell leukemia and multiple myeloma. Leukemia (2003) 0.94
Bone augmentation of the inferior floor of the maxillary sinus with autogenous bone or composite bone grafts: a histologic-histomorphometric preliminary report. Int J Oral Maxillofac Implants (1998) 0.94
Steroid pulses and plasmapheresis in the treatment of acute renal failure in multiple myeloma. Proc Eur Dial Transplant Assoc (1980) 0.94
Small bowel metastasis from squamous cell carcinoma of the larynx. A case report. Tumori (1993) 0.93
Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis. Cancer Detect Prev (1995) 0.93
Androgen receptor expression in male breast carcinoma: lack of clinicopathological association. Br J Cancer (1999) 0.92
Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: clinical relevance in 71 patients. Ann Oncol (1998) 0.91
Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases. Int J Cancer (2000) 0.91
Angiogenesis: prognostic significance in laryngeal cancer. Anticancer Res (1999) 0.90
Cell proliferation indices, morphometry and DNA flow cytometry provide objective criteria for distinguishing low and high grade bladder carcinomas. Virchows Arch (1994) 0.90
Study of ethmoidal mucosa in a population at occupational high risk of sinonasal adenocarcinoma. Acta Otolaryngol (2002) 0.90
Pluripotent stem cells isolated from human amniotic fluid and differentiation into pancreatic beta-cells. J Endocrinol Invest (2009) 0.89
Acute HIV-1 infection: clinical and biological study of 12 patients. J Acquir Immune Defic Syndr (1990) 0.89
Interferon alpha-2a treatment of relapsing-remitting multiple sclerosis: disease activity resumes after stopping treatment. Neurology (1996) 0.89
Analysis of the human CD36 leucocyte differentiation antigen by means of the monoclonal antibody NL07. Cell Immunol (1991) 0.88
Prolactin is an autocrine growth factor for the Jurkat human T-leukemic cell line. J Neuroimmunol (1997) 0.88
Human herpesvirus 6 and Epstein-Barr virus in Hodgkin's disease: a controlled study by polymerase chain reaction and in situ hybridization. Am J Pathol (1996) 0.88
True hermaphroditism with XX/XY sex chromosome mosaicism: report of a case. Clin Genet (1976) 0.88
Independent and synergistic effect of interleukin-2 and prolactin on development of T- and NK-derived LAK effectors. Immunopharmacology (1994) 0.87
Risk groups of myeloma patients by histologic pattern and proliferative activity. Am J Surg Pathol (1997) 0.87
Identification of a new epitope of the 4F2/44D7 molecular complex present on sarcolemma and isolated cardiac fibers. Eur J Immunol (1989) 0.87
Regulatory action of prolactin on the in vitro growth of CD34+ve human hemopoietic progenitor cells. J Cell Physiol (1995) 0.87
Point mutations of the BCL-6 gene: clinical and prognostic correlation in B-diffuse large cell lymphoma. Leukemia (2002) 0.87
Expression of prolactin and prolactin receptors by non-Hodgkin's lymphoma cells. Int J Cancer (2000) 0.86
Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study. Breast Cancer Res Treat (2014) 0.85
Altered patterns of the interferon-inducible gene IFI16 expression in head and neck squamous cell carcinoma: immunohistochemical study including correlation with retinoblastoma protein, human papillomavirus infection and proliferation index. Histopathology (2004) 0.85
Th1, Th2, Th17 and regulatory T cell pattern in psoriatic patients: modulation of cytokines and gene targets induced by etanercept treatment and correlation with clinical response. Dermatology (2011) 0.85
Association between Crohn's disease and Conn's syndrome. A report of two cases. Panminerva Med (2005) 0.85
Is transposed skin transformed in major head and neck mucosal reconstruction? Acta Otolaryngol (1995) 0.85
Circulating CD4+CD25 bright FOXP3+ T cells are up-regulated by biological therapies and correlate with the clinical response in psoriasis patients. Dermatology (2009) 0.85
Hepatocellular carcinoma complicating primary sclerosing cholangitis in Crohn's disease. A case report. Minerva Gastroenterol Dietol (2007) 0.85
A case of ulcerative jejunoileitis treated with anti tumor necrosis factor-alpha antibodies. Panminerva Med (2005) 0.85
p27(kip1) immunoreactivity correlates with long-term survival in pleural malignant mesothelioma. Cancer (2001) 0.85
Argyrophilic nucleolar organizer region counts in multiple myeloma: a histopathological study on bone marrow trephine biopsies. Virchows Arch A Pathol Anat Histopathol (1992) 0.85
Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade (grade 1) papillary carcinomas of the bladder. Am J Surg Pathol (2001) 0.84
Head and neck metastases of renal cancer after nephrectomy: a report of 2 cases. Tumori (1995) 0.84
Paraproteinemic variety of pure red cell aplasia: immunological studies in 1 patient. Acta Haematol (1978) 0.84
[Lymphadenopathy caused by Toxoplasma in an intramammary lymph node: role of molecular biology in the diagnosis]. Pathologica (1997) 0.84
An atypical verrucous carcinoma of the tongue arising in a patient with oral lichen planus associated with hepatitis C virus infection. Oral Oncol (1997) 0.84
The murine homolog of the HIN 200 family, Ifi 204, is constitutively expressed in myeloid cells and selectively induced in the monocyte/macrophage lineage. J Leukoc Biol (1998) 0.84
Prognostic factors for head and neck tumor recurrence. Acta Otolaryngol (1995) 0.84
Muscular cramps: proposals for a new classification. Acta Neurol Scand (2003) 0.83
Stage II large B-cell lymphoma with sclerosis treated with MACOP-B. Ann Oncol (1992) 0.83
Glomerular cell proliferation in human and experimental glomerulonephritis. Light- and electron-microscopical, and autoradiographic observations. Nephron (1977) 0.83
Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma. Clin Cancer Res (2000) 0.83
ZAP-70 is expressed by normal and malignant human B-cell subsets of different maturational stage. Leukemia (2006) 0.83